baber/WOPTO huggingface dataset:
Patent NZ-587624-A (NZ)
Title: Methods, systems, and compositions for the controlled crosslinking of well servicing fluids
Inventor: HAYDEN SHAUNA L
IPC: C09K8/68
Filed: 2009-02-27
Abstract: Disclosed is a composition for reducing the crosslinking time of aqueous polysaccharide solutions, the composition comprising: a) a polysaccharide blended with an aqueous base fluid; b) a borate crosslinking agent having a solubility in water at 22 degrees C (71.6 deg F) ranging from about 0.01 kg/m3 to about 10 kg/m3; and c) a reducing amount of a composition that accelerates the rate at which the borate crosslinking agent promotes the gelation of the polysaccharide, which comprises: (i) a first part selected from the group consisting of KCO2H (potassium formate) and KC2H3O2 (potassium acetate), in an amount of about 90 vol. percent up to about 98 vol. per cent based on the composition c); and (ii) a second part selected from the group consisting of CH3CO2H (acetate), HCO2H (formic acid), NaCO2H (sodium formate), NaC2H3O2 (sodium acetate), KCl (potassium chloride) and KOH (potassium hydroxide) in an amount of about 2 vol. per cent up to about 10 vol. percent based on the composition c). Also disclosed is a method of treating a subterranean formation, the method comprising: a) generating a treating fluid comprising a blend of an aqueous base fluid and a polysaccharide that is at least partially soluble in the aqueous base fluid; b) hydrating the treating fluid; c) generating a borate crosslinking composition comprising a borate crosslinking agent having a solubility in water at 22 degrees C (71.6 deg F) ranging from about 0.01 kg/m3 to about 10 kg/m3; d) generating a composition that controls the rate at which the borate crosslinking composition promotes the gelation of the polysaccharide, said composition comprising: (i) a first part selected from the group consisting of KCO2H (potassium formate) and KC2H3O2 (potassium acetate), in an amount of about 90 vol. percent up to about 98 vol. per cent based on the composition d); and (ii) a second part selected from the group consisting of CH3CO2H (acetate), HCO2H (formic acid), NaCO2H (sodium formate), NaC2H3O2 (sodium acetate), KCl (potassium chloride) and KOH (potassium hydroxide) in an amount of about 2 vol. per cent up to about 10 vol. percent based on the composition d). e) admixing compositions c) and d); adding the admixed composition e) to the hydrated treating fluid b) so as to increase or decrease the crosslinking of the treating fluid for a desired period of time measured in minutes; and g) delivering the treating fluid into a subterranean formation. The polysaccharide can be for example guar, cellulose, starch, galactomannan gum, xanthan, succinoglycan or scleroglucan
Patent NZ-588531-A (NZ)
Title: Carnallite-like food salts and products thereof
Inventor: MAKI TAPIO
IPC: A23L27/20
Filed: 2009-03-20
Abstract: Disclosed is a substantially non-hygroscopic carnallite triple salt for use in a food product having the formula: MgKx(NH4)yCIgzH2O Formula III where in the sum of x and y is about 1, wherein 0 < x < 1, wherein 0 < y < 1, wherein g is about 3, wherein z is about 4-6, and where in the triple salt for use in a food product is substantially non-hygroscopic and substantially free of hydrogen chloride.
Patent NZ-588971-A (NZ)
Title: Novel heterocyclic NF-kappaB inhibitors
Inventor: LEBAN JOHANN
IPC: A61K31/4535
Filed: 2006-03-15
Abstract: Disclosed is a carboxy amide substituted compound of formula (III) where the substituents are as disclosed it the specification. The compounds are useful as NF-kappaB inhibitors. Also disclosed is a composition comprising a compound of formula (III) and the use of a compound of formula (III) in the manufacture of a medicament for treating diseases characterized by hyperproliferation of cells such as epilepsy, stroke and Alzheimer's diseases. Examples of compounds are: 2-[3-(2-Trifluoromethoxy-phenyl)-ureido]-thiazole-4-carboxylic acid; 2-(2-Trifluoromethoxy-benzoylarnino)-thiazole-4-carboxylic acid (4-dimethylamino-[1,3,5]triazin-2-yl)-amide and 1-{ 4-[N'-(1H-Benzoimidazol-2-yl)-guanidinocarbonyl]-thiazol-2-yl} -3-(2-trifluoromethoxy-phenyl)-urea.
Patent NZ-589790-A (NZ)
Title: Rigging deck module
Inventor: HEANEY DAVID
IPC: B63B35/44
Filed: 2008-06-10
Abstract: 589790 A rigging deck module for performing maintenance on structures is disclosed. The module includes a deck body (10) including flexible deck material (12) bounded by a web-reinforced tensile edge (14, 16). Suspension means are spaced about the edge so the deck body is tensionable to form a substantially flat deck. A lattice of tensile web members (17) is secured to the flexible deck material (12) and the web-reinforced tensile edge (14, 16). The web lattice is contained within pockets of the deck body which is made of a stitched-and-glued and thermally welded assembly of polymer film or polymer web.
Patent NZ-589835-A (NZ)
Title: Manually retracted safety needle with rigid wing structure
Inventor: JONES SCOTT
IPC: A61M5/32
Filed: 2006-09-22
Abstract: A manually retracted safety needle device is provided having a rigid wing structure to stabilize the safety needle against the body of a patient. The safety needle device includes an elongate housing having a hub movably mounted therein. A tissue penetrating needle extends distally from the hub and a fluid conveying tube extends proximally from the hub. The rigid wing structure extends substantially along the length of the elongate member and, in one embodiment, includes wings extending transversely to a longitudinal axis of the elongate member. The safety needle is also provided with various finger gripping structures to facilitate manipulation of the safety needle device relative to the patient.
Patent NZ-590367-A (NZ)
Title: 9-Substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
Inventor: CIAPETTI PAOLA
IPC: A61P31/04
Filed: 2009-06-30
Abstract: Disclosed is a 9-substituted-5-carboxy-oxadiazino-quinolone derivative of formula (I), where R1 and R2 may be separate or joined in a ring as described, and where the substituents are as defined in the specification. Also disclosed is the use of the compounds as antibacterial agents.
Patent NZ-593410-A (NZ)
Title: Corn event 5307
Inventor: DE FRAMOND ANNICK JEANNE
IPC: A01H5/00
Filed: 2009-12-14
Abstract: 593410 Provided is a seed of a trans genic corn plant comprising insect control event 5307, an example of said seed deposited as ATCC Accession No. PTA-9561. Further provided is a transgenic event 5307 corn plant, cells and tissues thereof comprising at least one specified junction sequence and complements thereof. The plants contain the sequence coding for the insecticidal toxin FR8a agains Diabrotica spp. Insects as well as PMI gene encoding a phosphomannose isomerase enzyme useful as a selectable marker.
Patent NZ-593949-A (NZ)
Title: Substituted quinazoline compounds
Inventor: LE ROUX JACQUES
IPC: A61K31/502
Filed: 2009-12-18
Abstract: 593949 Disclosed are compounds of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) include: [(R)-1-(2-{ 4-[6-(2-Chloro-5-hydroxy-phenyl)-quinazolin-2-ylamino]-phenoxy} -acetyl)-pyrrolidin-3-yl]-dimethyl-ammonium; 4-Chloro-3-[2-(3-hydroxymethyl-phenylamino)-8-methyl-quinazolin-6-yl]-phenol; (R)-1-(2-{ 4-[6-(2-Chloro-5-hydroxy-phenyl)-8-methyl-quinazolin-2-ylamino]-phenoxy} -ethyl)-pyrrolidine-2-carboxylic acid. The compounds are useful in the treatment of a disorder involving tyrosine kinase dysregulation or an ophthalmic disorder such as myocardial infarction, stroke, congestive heart failure, an ischemia or reperfusion injury, trauma, cancer, oedema, arthritis or other arthropathy, retinopathy or vitreoretinal disease, diabetic retinopathy, macular oedema, including diabetic macular oedema, macular degeneration, glaucoma, autoimmune disease, vascular leakage syndrome, inflammatory disease, oedema, transplant rejection, burn, or acute or adult respiratory distress syndrome.
Patent NZ-599004-A (NZ)
Title: Detecting pax2 for the diagnosis of breast cancer
Inventor: DONALD CARLTON D
IPC: C12N15/11
Filed: 2009-08-25
Abstract: 599004 Discloses a method for monitoring breast conditions comrpsigin: Performing an assay to determine the expression level of Paired box 2 (PAX2) gene Performing an assay to determine the expression level of beta defensin-1 (DEFB1) Determining a PAX2-to-DEFB1 expression ratio based on the expression levels Correlating the PAX-to-DEFB1 ratio, wherein 100:1 of higher is indicative of a non-cancerous or pre-cancerous breast condition
Patent NZ-600025-A (NZ)
Title: Improved portafilter for espresso coffee machines
Inventor: BAMBI PIERO
IPC: A47J31/06
Filed: 2010-10-25
Abstract: 600025 A filter holder for espresso coffee machines is disclosed. The spout (22) is applied to a hollow upper member (10) of the filter holder by a snap fitting. The bottom (14) of the upper member is also provided with a relief shape (30), the edge (32) of which forms a stable supporting surface for pressing ground coffee into the cup of the holder. The filter holder is made entirely of polished stainless steel.
Patent NZ-600183-A (NZ)
Title: Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
Inventor: PLATENBURG GERARDUS JOHANNES
IPC: C12N15/86
Filed: 2009-05-14
Abstract: 600183 Provided is a nucleic acid molecule that binds and/or is complementary to nucleotide sequence: 5'-CUGUUGAGAAA whereby said molecule comprises 23, 24, 25, 26 or 27 nucleotides and comprises or consists of the base sequence of GCCAUUUCUCAACAGAUCUGUCA, wherein optionally one or more of said nucleotides is a nucleotide analogue. The
Patent NZ-601239-A (NZ)
Title: Synthetic intermediate of oxazole compound and method for producing the same
Inventor: FUJITA NOBUHISA
IPC: C07D498/04
Filed: 2011-01-28
Abstract: An object of the present disclosure is to provide a method for producing an oxazole compound in a high yield. The object can be achieved by a compound represented by Formula (11): wherein R1 is a hydrogen atom or lower-alkyl group; R2 is a 1-piperidyl group substituted at the 4-position with a substituent selected from (A1a) a phenoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1b) a phenoxy-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkyl groups, (A1c) a phenyl-substituted lower-alkoxy lower-alkyl group substituted on the phenyl moiety with halogen, (A1d) a phenyl-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1e) an amino group substituted with a phenyl group substituted with one or more halogen-substituted lower-alkoxy groups, and a lower-alkyl group, and (A1f) a phenyl-substituted lower-alkoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups; n is an integer from 1 to 6; and X3 is an organic sulfonyloxy group. In one embodiment the compound is (R)-1-[4-(2,3-epoxy-2-methylpropoxy)phenyl]-4-[4-(trifluoromethoxy)phenoxy]piperidine.
Patent NZ-602536-A (NZ)
Title: Shock resistant foundation system for building
Inventor: MAJKIC BOGDAN
IPC: E02D27/34
Filed: 2012-09-20
Abstract: 602536 Disclosed is a foundation system for a building to enable more efficient construction. The system includes a footing system, an array of resilient plates supported on the footing system, and an array of precast concrete elements supported on the array of resilient plates. The precast concrete elements and the resilient plates are secured to the strip footing system, and the precast concrete elements are secured to each other, such that the array of resilient plates is configured to at least partially absorb movement of the ground on which the foundation system is supported. The precast concrete elements have rebated edges at their top surfaces, such that a series of channels is formed between adjacent precast concrete elements. A top layer of concrete which fills the series of channels to lock the precast concrete elements together.
Patent NZ-612188-A (NZ)
Title: A method of producing sugar from paper
Inventor: MEDOFF MARSHALL
IPC: C13K1/02
Filed: 2012-02-14
Abstract: The disclosure relates to a method of producing an alcohol product or intermediate, comprising: combining a slurry of paper with a saccharifying agent in a vessel, the paper having a filler content greater than about 10wt%; allowing at least a portion of the paper to saccharify producing sugar, while mixing the contents of the vessel with a jet mixer and fermenting at least a portion of the sugar with a microorganism, where the contents of the vessel comprise at least one shear sensitive ingredient and the jet mixer provides gentle mixing so as to minimize damage.
Patent NZ-617003-A (NZ)
Title: Method to use gene expression to determine likelihood of clinical outcome of renal cancer
Inventor: SHAK STEVEN
IPC: G06F19/00
Filed: 2011-01-07
Abstract: Disclosed is a method for determining a likelihood of recurrence of renal cell carcinoma for a patient with renal cell carcinoma comprising: (a) measuring in a renal cell carcinoma sample obtained from the patient, a level of an RNA transcript of APOLD1, or its expression product; (b) normalising the level of the RNA transcript of APOLD1, or its expression product to obtain a normalised APOLD1 expression level; and (c) determining a likelihood of recurrence of renal cell carcinoma for the patient based on the normalised APOLD1 expression level, wherein increased normalised APOLD1 expression level is negatively correlated with likelihood of recurrence of renal cell carcinoma.
Patent NZ-622531-A (NZ)
Title: Bicycle fork securing device
Inventor: SAUTTER CHRIS
IPC: B60R9/048
Filed: 2012-09-13
Abstract: A bike rack (12) including an elongate body (22) having a first end portion (26) and a second end portion (24), a rear wheel receiver (24) connected to the body adjacent the second end portion. A fork mount device (10) connected to the body adjacent the first end portion. The fork mount device includes a body and a pair of retractable axle portions configured to move between a retracted position in which the axle portions are substantially contained in the body, and an extended position in which the axle portions extend sufficiently to engage axle holes of a 15QR or 15mm through-hole quick release bicycle fork.
Patent NZ-625010-A (NZ)
Title: Apparatus for preventing over inflation of the retention balloon in medical catheters and airway devices
Inventor: GREGORY CHRISTOPHER
IPC: A61M25/04
Filed: 2012-11-15
Abstract: An apparatus for limiting fluid pressure in a medical catheter retention balloon includes a body that has a fluid inlet port 42 for receiving pressurized fluid and a fluid outlet port 44 connected to the retention balloon. A first passage 40a, 40b, 52, 54 connects the fluid inlet port and the fluid outlet port. A second passage 46a, 46b in the body is connected to the balloon fluid return path 48 and is at the pressure of the retention balloon. A valve 50, 60 prevents fluid flow through the first passage 52 54 when actuated by a pressure-responsive member 60 and is movable to a position to obstruct fluid flow in response to fluid pressure in the second passage exceeding the predetermined level. The ball check valve 56 allows fluid to be withdrawn from the balloon by way of suction applied to inlet port 42.
Patent NZ-625184-A (NZ)
Title: Cationic polymers comprising a hydrophobic group as deposition enhancers for pesticides and crop production chemicals
Inventor: WESTBYE PETER
IPC: A01N39/04
Filed: 2012-12-17
Abstract: Disclosed is an aqueous composition comprising 0.005 to 0.5 wt% of a hydrophobically modified cationic polymer, prepared by polymerising an alkyl ester of acrylic acid or an alkyl ester of methacrylic acid, a nitrogen containing monomer; and an associative monomer. The composition is suitable as deposition enhancers for pesticides and crop production chemicals, such as plant growth regulators, fertilizers and micronutrients, in aqueous solutions. In a particular embodiment, the alkyl ester of acrylic acid is ethyl acrylate and the nitrogen monomer is N,N-dimethylamino ethyl methacrylate (DMAEMA).
Patent NZ-703128-A (NZ)
Title: Pharmaceutical formulations comprising 1 - (beta-d-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of sglt
Inventor: WANG WENHUA
IPC: A61P3/10
Filed: 2011-05-11
Abstract: The disclosure relates to 1-(β-D-glucopyranosyl)-2-thienylmethylbenzene derivatives of formula (I), wherein the variables are as defined in the specification. These compounds are suitable for treating or delaying the progression or onset of a sodium-dependent glucose transporter mediated disorder selected from diabetes mellitus, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, delayed wound healing, insulin resistance, hyperglycemia, hyperinsulinemia, elevated blood levels of fatty acids, elevated blood levels of glycerol, hyperlipidemia, obesity, hypertriglyceridemia, Syndrome X, diabetic complications, atherosclerosis, or hypertension.
Patent NZ-713333-A (NZ)
Title: Fastener with prolate cross-section
Inventor: PARK JEREMY SCOTT
IPC: F16B25/00
Filed: 2014-03-20
Abstract: A fastener includes a shank having a point at a first end and a second, head end. One or more prolate cross-section regions is formed in the shank. Prolate cross-section regions may be formed in a threaded section and/or a thread free section of the fastener. Each prolate cross-section may have a polar diameter greater than the cylindrical diameter of the region in which it is formed and an equatorial diameter smaller than the corresponding cylindrical diameter of the region in which it is formed. Two generally adjacent prolate cross-section regions have cross-sections offset with respect to each other by an angle between zero and ninety-degrees. The prolate cross-sections reduce torque by creating a larger bore for the following shank section, thereby allowing the fastener to be installed into a fastening material in a recessed fashion more easily than prior embodiments. The prolate cross-sections also render the fastener easier to manufacture.
Patent NZ-724912-A (NZ)
Title: Transmucosal drug delivery devices for use in chronic pain relief
Inventor: VASISHT NIRAJ
IPC: A61K31/485
Filed: 2012-12-21
Abstract: Provided are uses of a transmucosal drug delivery device comprising buprenorphine in the manufacture of a medicament for treating chronic pain with a low incidence of adverse effects. The device comprises a bioerodable mucoadhesive layer comprising buprenorphine disposed in a buffered polymeric diffusion environment, wherein the polymeric diffusion environment is a buffered environment having a pH of between about 4 and about 6, and a backing layer buffered to a pH of between about 4.0 and about 4.8 and that does not include an opioid antagonist.
Patent NZ-725135-A (NZ)
Title: A method and apparatus for pressing oilseed to extract oil therefrom
Inventor: HEWITT NEIL JAMES
IPC: B30B15/34
Filed: 2015-03-31
Abstract: A method of extracting oil from oilseed comprising pressing seeds within a screw press including a screw auger rotatably mounted within a cylindrical expeller body, wherein the expeller body comprises a feed section, a compression section, and a discharge section, wherein at least one outlet is provided in the expeller body, preferably in or adjacent the feed section of the expeller, said method comprising the step of controlling the temperature of at least the compression section of the expeller by means such that the temperature of the material within the compression section does not exceed the glass transition temperature of the seeds.
Patent NZ-731753-A (NZ)
Title: Anti-hcmv compositions and methods
Inventor: REMISZEWSKI STACY
IPC: C07D217/02
Filed: 2015-11-09
Abstract: Thiazole derivatives of formula I useful in treating and/or preventing human cytomegalovirus (HGMV) infections
Patent NZ-742166-A (NZ)
Title: Greeting card with gift card holder
Inventor: JENNIFER DADANTE
IPC: B42D15/04
Filed: 2018-05-02
Abstract: A combined greeting card and gift card holder which also includes audio capability and motor movement of at least one mobile object attached to or integral with the greeting card. The greeting card may additionally contain certain embellishments such as faux fur to make the greeting card more appealing and entertaining.
Patent NZ-747655-A (NZ)
Title: Conditioner unit
Inventor: BODE MORTENSEN MARTIN
IPC: A01D82/02
Filed: 2017-04-26
Abstract: A conditioner unit for conditioning an agricultural crop material by bruising and crushing stalks of the crop material, comprising a pair of rolls configured for rotation in opposite directions and providing a nip through which crop material passes, each said roll having a roll surface that contacts the crop material and interlocking surface formations that are configured to deform the crop material as it passes through the nip between the rolls, and an adjusting mechanism for adjusting a pressing force applied by the rolls to the crop material as it passes through the nip, wherein the adjusting mechanism includes at least one hydraulic actuator connected to at least one of the rolls and a hydraulic circuit that supplies hydraulic fluid to the actuator, wherein the hydraulic circuit is configured so that in a first operational mode the rolls are pressed towards one another by the actuator in a closed working condition, and in a second operational mode the rolls are pushed apart by the actuator in an open non-working condition to provide a gap between the rolls to allow cleaning of the rolls, and wherein the hydraulic actuator is a double-acting hydraulic cylinder having first and second chambers, the hydraulic circuit being configured such that in the first operational mode the hydraulic pressure is greater in the first chamber, and in the second operational mode the hydraulic pressure is greater in the second chamber.
Patent NZ-776411-A (NZ)
Title: Fluid pumping and bioreactor system
Inventor: KAMEN DEAN
IPC: C12M3/00
Filed: 2016-10-07
Abstract: Provided herein is a bioreactor for a set for decellularizing tissue, the bioreactor comprising: an adapter including a first face and an second face opposing the first face; an enclosure including a first section and a second section, the first section including a first side and a second side, the enclosure including a liquid-tight seal between the first section and the first face, the enclosure including at least one enclosure pass-through, the enclosure including a liquid-tight seal between at least a portion of the second section and at least a portion of the first section; a first fluid line operably coupled to the adapter, the first fluid line coupling the at least one enclosure pass-through and the adapter; a second fluid line disposed on the second face, the second fluid line fluidically coupled with the first fluid line, the first fluid line coupled with the second fluid line forming a closed fluid path; and wherein the adapter comprises a first adapter part and a second adapter part, wherein the first adapter part is attached to an interior surface of the enclosure, wherein the second adapter part is attached to an exterior surface of the enclosure, wherein the first adapter part and the second adapter part each comprise a plurality of respective adapter part pass-throughs, wherein each of the adaptor part pass-throughs of the first adaptor part is configured for alignment with a respective one of the plurality of adaptor part pass-throughs of the second adaptor part when the first adapter part and the second adapter part are attached to the enclosure, wherein the bioreactor includes at least one bioreactor port configured to fluidically connect the bioreactor to at least one pump cassette of the set for decellularizing tissue.